409
Views
53
CrossRef citations to date
0
Altmetric
Original

Demographic and Psychosocial Characteristics of Mothers Using Methamphetamine During Pregnancy: Preliminary Results of the Infant Development, Environment, and Lifestyle Study (IDEAL)

, M.D., , Ph.D., , M.D., , M.D., , M.D., , Ph.D., , Ph.D., , M.D., , M.D., , M.P.H., , Ph.D. & , Ph.D. show all
Pages 281-289 | Published online: 07 Jul 2009

REFERENCES

  • “Greenblatt JC, Gfroerer JC. (1996). Methamphetamine abuse in the United States. Rockville, MD: U. S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies”.
  • Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000; 32(2):137–141.
  • Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993; 329(12):850–854.
  • Derauf C, Katz AR, Frank DA, Grandinetti A, Easa D. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. J Drug Issues 2003; 3(4):1001–1016.
  • Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, Huestis M, Strauss A, Grotta SD, Liu J, Lester B. Methamphetamine and other substance use during pregnancy: Preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Matern Child Health J (Online First) 2006; Jan 5:1–10.
  • Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol 1999; 26(1):55–74.
  • Nair P, Black MM, Schuler M, Keane V, Snow L, Rigney BA, Magder L. Risk factors for disruption in primary caregiving among infants of substance abusing women. Child Abuse Negl 1997; 21(11):1039–1051.
  • Arendt RE, Short EJ, Singer LT, Minnes S, Hewitt J, Flynn S, Carlson L, Min MO, Klein N, Flannery D. Children prenatally exposed to cocaine: Developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr 2004; 25(2):83–90.
  • Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
  • Derogatis LR. Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. 3rd ed. Minneapolis: National Computer Systems, Inc., 1993.
  • Miller FG, Roberts J, Brooks MK, Lazowski LE. Sassi-3 User's Guide. Bloomington, IN: Baugh Enterprises, Inc., 1997.
  • Blackwell TL, Toriello PL. Test review: substance abuse subtle screening inventory–3. Rehabilitation Counseling Bulletin 2005; 48(4):248–250.
  • Furstenberg FF, Hughes ME. Social capital and successful development. J Marriage and the Family 1995; 57:580–592.
  • Nair P, Schuler ME, Black MM, Kettinger L, Harrington D. Cumulative environmental risk in substance abusing women: Early intervention, parenting stress, child abuse potential, and child development. Child Abuse Negl 2003; 27(9):997–1017.
  • Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Lu J, Finnegan LP, Maza PL. The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110(6):1182–1192.
  • Conners NA, Bradley RH, Mansell LW, Liu JY, Roberts TJ, Burgdorf K, Herrell JM. Children of mothers with serious substance abuse problems: An accumulation of risks. Am J Drug Alcohol Abuse 2004; 30(1):85–100.
  • Joe KA. The lives and times of Asian-Pacific American drug users: An ethnographic study of their methamphetamine use. J Drug Issues 1996; 26(1):199–218.
  • Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M. Methamphetamine treatment project. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13:181–190.
  • Semple SJ, Grant I, Patterson TL. Female methamphetamine users: Social characteristics and sexual risk behavior. Women & Health 2004; 40(3):35–50.
  • Bisagno V, Bowman R, Luine V. Functional aspects of estrogen neuroprotection. Endocrine 2003; 21(1):33–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.